Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 619-447-3 | CAS number: 99607-70-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 23 June 1998 to 03 September1998
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5375 - In vitro Mammalian Chromosome Aberration Test
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate
- EC Number:
- 619-447-3
- Cas Number:
- 99607-70-2
- Molecular formula:
- C18H22ClNO3
- IUPAC Name:
- heptan-2-yl [(5-chloroquinolin-8-yl)oxy]acetate
- Details on test material:
- - Name of test material (as cited in study report): CGA185072 technical
- Analytical purity: 97%
- Physical state: beige powder
- Expiration date of the lot/batch: reanalysis date 31 December 1999
- Stability: confirmed
Constituent 1
Method
- Target gene:
- Chinese hamster ovary cells (ATCC CCL61)
Species / strain
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor induced rat liver S9
- Test concentrations with justification for top dose:
- Cytotoxicity test: 0, 0.39, 0.78, 1.56, 3.13, 6.25, 12.50, 25 and 50 µg/mL
Experiments without metabolic activation: 0, 6.25, 12.50 and 25.00 µg/mL
Experiments with metabolic activation: 0, 12.50, 25.00 and 50.00 µg/mL - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- without S9 Migrated to IUCLID6: 0.2 µg/mL
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with S9 Migrated to IUCLID6: 20.0 µg/mL
- Details on test system and experimental conditions:
- DURATION
- Preincubation period: approximately 24 hours
- Exposure duration: 21 or 45 hours (without S9); 3 hours treatment followed by 18 hours recovery or 3 hours treatment followed by 18 hours recovery (with S9)
SPINDLE INHIBITOR
- Two hours prior to harvesting, the cultures were treated with 0.4 µg/mL Colcemide to arrest cells in metaphase. After harvesting the cells were spread on glass slides and air dried.
NUMBER OF REPLICATIONS: 4
NUMBER OF CELLS EVALUATED:
- The percentage of mitotic suppression was determined by evaluating at least 2000 cells from each slide. Whenever possible two hundred well spread metaphase figures with 19 to 21 centromeres from two cultures (100 metaphases per replicate culture) in the vehicle control and in the treated groups were scored. At least fifty metaphases were scored in the positive controls (25 per replicate culture).
- The slides were examined for specific and unspecific structural aberrations.
- The percentages of mitotic suppression, in comparison with the controls, were evaluated by counting at least 2000 cells per slide for each treatment group.
DETERMINATION OF CYTOTOXICITY
- Determination of cloning efficiency: Cell cultures were exposed to the test substance for 3 hours in the presence of a metabolic activation system. Four concentrations of the test substance and the vehicle (DMSO) control were tested. The treatment was terminated by washing the cultures with phosphate buffered saline (PBS). The cells were then suspended by trypsinisation, pelleted, resuspended in fresh growth medium and counted with a haemocytometer. The cultures were diluted so that 100 cells were seeded per 9.6 cm² in 3 ml of growth medium. After seven to eight days of growth at 37°C the cultures were fixed and stained with Giemsa and the surviving colonies (cloning efficiency) were determined by eye. - Evaluation criteria:
- Criterion for positive response based on an increased incidence of specific chromosomal aberrations.
Criteria for a positive test: the percentage of metaphases containing specific aberrations in a treatment group is higher than 6.0, and differs statistically from the respective negative control, with a demonstrable concentration-related response.
Criteria for a negative response: percentage of metaphases containing specific aberrations in a treatment group is less than or equal to 6.0, and does not differ statistically from the respective negative control. - Statistics:
- Not applicable
Results and discussion
Test results
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Analysis for test article content of the lowest, by serial dilution prepared stock solutions used in the mutagenicity test revealed that the test article was stable in the vehicle used and that the cells were exposed to the intended concentrations. The actual concentrations ranged between 94.4 –95.6% of the nominal concentrations.
Cytotoxicity test - Concentrations higher than 50 µg/mL could not be tested, due to solubility limitations of the test substance in the vehicle DMSO. In the experiments with and without metabolic activation, marked cytotoxicity was observed at the highest concentrations.
In all experiments performed with or without metabolic activation no statistically significant increase in the number of metaphases containing specific chromosomal aberrations was observed. - Remarks on result:
- other: strain/cell type: CHO cells ATCC CCL61
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 1: CGA185072: Mitotic Index (% of control) of CHO cells
|
Original study |
Confirmatory study |
||||
Experiment |
1 |
2 |
3 |
4 |
5 |
6 |
Metabolic Activation |
- |
+ |
- |
+ |
- |
+ |
Treatment (h) |
21 |
3 |
21 |
3 |
45 |
3 |
Recovery (h) |
- |
18 |
- |
18 |
- |
42 |
CGA185072 |
|
|
|
|
|
|
50.00 µg/mL |
0 |
95 |
0 |
138 |
1 |
79 |
25.00 µg/mL |
20 |
107 |
19 |
106 |
50 |
95 |
12.50 µg/mL |
103 |
96 |
89 |
93 |
89 |
99 |
6.25 µg/mL |
96 |
|
71 |
|
128 |
|
3.13 µg/mL |
109 |
|
94 |
|
87 |
|
1.56 µg/mL |
|
|
|
|
|
|
0.78 µg/mL |
|
|
|
|
|
|
0.39 µg/mL |
|
103 |
|
101 |
|
94 |
Table 2: Percent incidence of specific chromosomal aberrations in CHO cells treated with CGA185072
|
Original study |
Confirmatory study |
||||
Experiment |
1 |
2 |
3 |
4 |
5 |
6 |
Metabolic Activation |
- |
+ |
- |
+ |
- |
+ |
Treatment (h) |
21 |
3 |
21 |
3 |
45 |
3 |
Recovery (h) |
- |
18 |
- |
18 |
- |
42 |
Negative control |
2.0 |
2.0 |
2.5 |
2.0 |
3.0 |
3.5 |
CGA185072 |
|
|
|
|
|
|
50.00 µg/mL |
|
|
|
|
|
|
25.00 µg/mL |
|
3.0 |
|
4.0 |
|
4.0 |
12.50 µg/mL |
3.0 |
2.0 |
4.5 |
4.5 |
2.5 |
1.0 |
6.25 µg/mL |
2.0 |
2.5 |
0.5 |
3.5 |
3.0 |
3.0 |
3.13 µg/mL |
0.5 |
|
2.0 |
|
2.0 |
|
1.56 µg/mL |
|
|
|
|
|
|
0.78 µg/mL |
|
|
|
|
|
|
|
|
|
|
|
|
|
Positive controla,b |
80.0*** |
60.0*** |
80.0*** |
70.0*** |
|
|
200 cells with well spread metaphase figures were scored, except for positive controls where 50 cells were scored.
- no positive control
aCyclophosphamide, 20 µg/mL bMitomycin-C, 0.2 µg/mL
* p ≥ 0.05; *** p ≤ 0.001 (Chi-square test)
Applicant's summary and conclusion
- Conclusions:
- negative with and without metabolic activation
- Executive summary:
The clastogenicity of the test substance was tested under GLP to OECD TG 473 in an in vitro study. Chinese hamster ovary cells (ATCC CCL61) were incubated with several concentrations of cloquintocet-mexyl. Mitomycin C (0.2 µg/mL, without metabolic activation), and cyclophosphamide (20.0 µg/mL, with metabolic activation), were used as positive controls. Experiments without metabolic activation were conducted at 0, 6.25, 12.50 and 25.00 µg/mL in the main study, experiments with metabolic activation were conducted at 0, 12.50, 25.00 and 50.00 µg/mL in the main study.
In all experiments performed with or without metabolic activation, no statistically significant increase in the number of metaphases containing specific chromosomal aberrations was observed.
Cloquintocet-mexyl caused no clastogenic effects in Chinese hamster ovary cells in vitro.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.